Healthcare companies by risk reading
Healthcare companies by risk reading: 1,695 companies ranked by a composite risk reading built from filed statements -- leverage, cash conversion, operating pressure, customer and supplier concentration and competitive position. Recomputed 21 October 2026.
Composite readings for 14,899 companies, recomputed 21 October 2026. A company appears here once at least three weighted categories cleared their inputs; the rest carry per-mechanism readings without a headline.
| Company | Reading | Band | Sector | Country | Coverage | Market cap |
|---|---|---|---|---|---|---|
| Oncoinvent ASA ONCIN | 43 | Elevated | Healthcare | Norway | 5 / 6 | $45M |
| Austar Lifesciences Limited 6118.HK | 45 | Elevated | Healthcare | China | 5 / 6 | $44M |
| INmune Bio Inc INMB | 68 | Stretched | Healthcare | United States | 4 / 6 | $44M |
| Actinium Pharmaceuticals Inc ATNM | 66 | Stretched | Healthcare | United States | 4 / 6 | $44M |
| HC Surgical Specialists Limited 1B1.SI | 28 | Normal | Healthcare | Singapore | 5 / 6 | $44M |
| Yunkang Group Limited 2325.HK | 44 | Elevated | Healthcare | China | 5 / 6 | $44M |
| Arovella Therapeutics Limited ALA.AX | 56 | Elevated | Healthcare | Australia | 3 / 6 | $43M |
| ADR Biomedical Holdings Inc. 3750.T | 70 | Stretched | Healthcare | Japan | 4 / 6 | $43M |
| SomnoMed Limited SOM.AX | 32 | Normal | Healthcare | Australia | 3 / 6 | $43M |
| Broncus Holding Corporation 2216.HK | 56 | Elevated | Healthcare | China | 5 / 6 | $43M |
| Senzime AB SEZI | 53 | Elevated | Healthcare | Sweden | 4 / 6 | $42M |
| ContextVision AB CONTX | 23 | Normal | Healthcare | Sweden | 4 / 6 | $42M |
| AgeX Therapeutics Inc SER | 51 | Elevated | Healthcare | United States | 5 / 6 | $42M |
| Tsubota Laboratory Incorporated 4890.T | 85 | Acute | Healthcare | Japan | 5 / 6 | $42M |
| Xtant Medical Holdings Inc XTNT | 37 | Normal | Healthcare | United States | 6 / 6 | $42M |
| ABL Diagnostics ABLD.PA | 36 | Normal | Healthcare | France | 5 / 6 | $42M |
| Ekso Bionics Holdings Inc EKSO | 80 | Acute | Healthcare | United States | 5 / 6 | $42M |
| Cryosite Limited CTE.AX | 20 | Normal | Healthcare | Australia | 4 / 6 | $41M |
| UMP Healthcare Holdings Limited 0722.HK | 34 | Normal | Healthcare | Hong Kong | 4 / 6 | $41M |
| Cutia Therapeutics 2487.HK | 55 | Elevated | Healthcare | China | 5 / 6 | $41M |
| Aiforia Technologies Oyj AIFORIA | 61 | Stretched | Healthcare | Finland | 5 / 6 | $41M |
| Little Green Pharma Ltd LGP | 22 | Normal | Healthcare | Australia | 4 / 6 | $41M |
| ARECOR THERAPEUTICS -01 6UI | 57 | Elevated | Healthcare | United Kingdom | 5 / 6 | $41M |
| SUSMED,Inc. 4263.T | 74 | Stretched | Healthcare | Japan | 4 / 6 | $40M |
| Shigematsu Works Co., Ltd. 7980.T | 34 | Normal | Healthcare | Japan | 5 / 6 | $40M |
| BioRestorative Therapies Inc BRTX | 53 | Elevated | Healthcare | United States | 3 / 6 | $40M |
| CellSource Co., Ltd. 4880.T | 34 | Normal | Healthcare | Japan | 5 / 6 | $40M |
| B.M.P. PHARMA TRAD (BMP.SG) BMP | 39 | Normal | Healthcare | Germany | 4 / 6 | $40M |
| Zhong Ji Longevity Science Group Limited 0767.HK | 39 | Normal | Healthcare | Hong Kong | 5 / 6 | $39M |
| KLEA HOLDING ALKLH.PA | 16 | Contained | Healthcare | France | 5 / 6 | $39M |
| WDB coco Co., Ltd. 7079.T | 24 | Normal | Healthcare | Japan | 5 / 6 | $39M |
| Meihao Medical Group Co., Ltd 1947.HK | 40 | Elevated | Healthcare | China | 5 / 6 | $39M |
| Cyfuse Biomedical K.K. 4892.T | 71 | Stretched | Healthcare | Japan | 5 / 6 | $39M |
| Piu' Medical PMED.MI | 45 | Elevated | Healthcare | Italy | 3 / 6 | $39M |
| Precipio Inc PRPO | 33 | Normal | Healthcare | United States | 5 / 6 | $39M |
| Rapid Micro Biosystems Inc - Class A RPID | 41 | Elevated | Healthcare | United States | 6 / 6 | $39M |
| Cryo-Cell International Inc CCEL | 45 | Elevated | Healthcare | United States | 4 / 6 | $38M |
| Nephros Inc NEPH | 22 | Normal | Healthcare | United States | 6 / 6 | $38M |
| UG Healthcare Corporation Limited 8K7.SI | 18 | Contained | Healthcare | Singapore | 5 / 6 | $38M |
| Pharmx Technologies Limited PHX.AX | 56 | Elevated | Healthcare | Australia | 4 / 6 | $38M |
| MACH7 Technologies Ltd M7T | 81 | Acute | Healthcare | United States | 3 / 6 | $38M |
| Harvard Bioscience Inc HBIO | 64 | Stretched | Healthcare | United States | 5 / 6 | $38M |
| Nasus Pharma Ltd NSRX | 40 | Elevated | Healthcare | Israel | 4 / 6 | $38M |
| Singular Health Group Ltd SHG.AX | 50 | Elevated | Healthcare | Australia | 4 / 6 | $38M |
| BrightPath Biotherapeutics Co., Ltd. 4594.T | 79 | Stretched | Healthcare | Japan | 4 / 6 | $38M |
| Scynexis Inc SCYX | 31 | Normal | Healthcare | United States | 3 / 6 | $38M |
| Biohit Oyj B BIOBV | 28 | Normal | Healthcare | Finland | 5 / 6 | $38M |
| Sinco Pharmaceuticals Holdings Limited 6833.HK | 36 | Normal | Healthcare | China | 5 / 6 | $38M |
| Novacyt ALNOV | 59 | Elevated | Healthcare | France | 5 / 6 | $37M |
| Precision System Science Co., Ltd. 7707.T | 36 | Normal | Healthcare | Japan | 4 / 6 | $37M |
| CVRx Inc CVRX | 60 | Stretched | Healthcare | United States | 6 / 6 | $37M |
| Pharmarise Holdings Corporation 2796.T | 26 | Normal | Healthcare | Japan | 5 / 6 | $37M |
| Soiken Holdings Inc. 2385.T | 75 | Stretched | Healthcare | Japan | 3 / 6 | $37M |
| Arecor Therapeutics plc AREC.L | 47 | Elevated | Healthcare | United Kingdom | 5 / 6 | $37M |
| AROVELLA THERAPEUTICS E4NA | 67 | Stretched | Healthcare | Australia | 3 / 6 | $37M |
| ClouDr Group Limited 9955.HK | 65 | Stretched | Healthcare | China | 5 / 6 | $37M |
| Shanghai Bio-heart Biological Technology Co., Ltd. 2185.HK | 69 | Stretched | Healthcare | China | 4 / 6 | $37M |
| Human Health Holdings Limited 1419.HK | 35 | Normal | Healthcare | Hong Kong | 5 / 6 | $37M |
| Celularity Inc - Class A CELU | 59 | Elevated | Healthcare | United States | 5 / 6 | $36M |
| SMAIO SA ALSMA | 25 | Normal | Healthcare | France | 5 / 6 | $36M |
| Elutia Inc - Class A ELUT | 64 | Stretched | Healthcare | United States | 5 / 6 | $36M |
| Nippon Chemiphar Co., Ltd. 4539.T | 37 | Normal | Healthcare | Japan | 5 / 6 | $36M |
| Generation Bio Company GBIO | 55 | Elevated | Healthcare | United States | 5 / 6 | $36M |
| Care Twentyone Corporation 2373.T | 31 | Normal | Healthcare | Japan | 5 / 6 | $36M |
| Living Platform,Ltd. 7091.T | 25 | Normal | Healthcare | Japan | 5 / 6 | $35M |
| Cyclopharm Limited CYC.AX | 89 | Acute | Healthcare | Australia | 4 / 6 | $35M |
| Transcenta Holding Limited 6628.HK | 84 | Acute | Healthcare | China | 5 / 6 | $35M |
| Bioretec Oy BRETEC | 73 | Stretched | Healthcare | Finland | 4 / 6 | $35M |
| ONCOTHERAPY SCIENCE INC. 30O | 71 | Stretched | Healthcare | Japan | 4 / 6 | $35M |
| EyePoint Pharmaceuticals Inc EYPT | 78 | Stretched | Healthcare | United States | 5 / 6 | $35M |
| Incannex Healthcare Inc IXHL | 57 | Elevated | Healthcare | Australia | 4 / 6 | $34M |
| Evaxion Biotech A/S EVAX | 53 | Elevated | Healthcare | Denmark | 5 / 6 | $34M |
| Compumedics Limited CMP.AX | 36 | Normal | Healthcare | Australia | 4 / 6 | $34M |
| Q linea AB QLINEA | 98 | Acute | Healthcare | Sweden | 3 / 6 | $34M |
| INMOLECULE MLINA.PA | 30 | Normal | Healthcare | Spain | 3 / 6 | $34M |
| Modern Chinese Medicine Group Co., Ltd. 1643.HK | 61 | Stretched | Healthcare | China | 5 / 6 | $33M |
| Accrelist Ltd. QZG.SI | 40 | Elevated | Healthcare | Singapore | 5 / 6 | $33M |
| Phaos Technology (Cayman) Holdings Ltd - Class A POAS | 85 | Acute | Healthcare | Singapore | 4 / 6 | $33M |
| Botanix Pharmaceuticals Ltd BOT | 63 | Stretched | Healthcare | Australia | 4 / 6 | $33M |
| Q-Linea QLINEA.ST | 98 | Acute | Healthcare | Sweden | 3 / 6 | $33M |
| Navamedic ASA NAVA | 30 | Normal | Healthcare | Norway | 5 / 6 | $33M |
| PRISM BioLab Co.,LTD 206A.T | 67 | Stretched | Healthcare | Japan | 4 / 6 | $33M |
| Medical Developments International Limited MVP.AX | 9 | Contained | Healthcare | Australia | 4 / 6 | $32M |
| NexgenRX Inc. NXG | 19 | Contained | Healthcare | Canada | 4 / 6 | $32M |
| Regent Pacific Group Limited 0575.HK | 58 | Elevated | Healthcare | Hong Kong | 5 / 6 | $32M |
| NicOx S.A. ALCOX | 36 | Normal | Healthcare | France | 4 / 6 | $32M |
| QT Imaging Holdings Inc Com QTI | 61 | Stretched | Healthcare | United States | 5 / 6 | $32M |
| Entero Therapeutics Inc GRDX | 76 | Stretched | Healthcare | United Kingdom | 3 / 6 | $32M |
| Veraxa Biotech AG VRXA | 81 | Acute | Healthcare | Germany | 4 / 6 | $32M |
| Kringle Pharma, Inc. 4884.T | 89 | Acute | Healthcare | Japan | 3 / 6 | $31M |
| Metagenomi Inc MGX | 68 | Stretched | Healthcare | United States | 6 / 6 | $31M |
| Aligos Therapeutics Inc ALGS | 64 | Stretched | Healthcare | United States | 5 / 6 | $31M |
| CervoMed Inc CRVO | 71 | Stretched | Healthcare | United States | 3 / 6 | $31M |
| Hi-CRATES CO.,LTD. 4172.T | 25 | Normal | Healthcare | Japan | 4 / 6 | $31M |
| Micro-X Limited MX1.AX | 65 | Stretched | Healthcare | Australia | 4 / 6 | $31M |
| Sangamo Therapeutics Inc SGMO | 86 | Acute | Healthcare | United States | 5 / 6 | $31M |
| Rainmed Medical Limited 2297.HK | 84 | Acute | Healthcare | China | 5 / 6 | $30M |
| Milestone Scientific Inc MLSS | 57 | Elevated | Healthcare | United States | 6 / 6 | $30M |
| Tianda Pharmaceuticals Limited 0455.HK | 63 | Stretched | Healthcare | Hong Kong | 5 / 6 | $30M |
| DarioHealth Corp DRIO | 64 | Stretched | Healthcare | United States | 5 / 6 | $30M |
By sector
Industrials 3,117Technology 2,425Consumer Cyclical 2,231Healthcare 1,695Consumer Defensive 1,055Basic Materials 1,055Real Estate 1,011Communication Services 956Energy 487Utilities 343Financial Services 90
How the reading is built
Each company is scored on six mechanisms -- market expectation, operating pressure, cash conversion, leverage, concentration and competitive position -- from its own filed statements. A mechanism whose inputs do not clear its coverage floor is left unread rather than scored zero, and a reading built on thin coverage is pulled toward a neutral prior rather than claiming safety from what nobody looked at.
Descriptive, not advisory. These bands describe measured mechanisms; they are not investment advice, not a forecast, and not a statement about whether a share is worth owning.